Literature DB >> 11943161

The putative effector-binding site of Leishmania mexicana pyruvate kinase studied by site-directed mutagenesis.

Véronique Hannaert1, Cédric Yernaux, Daniel J Rigden, Linda A Fothergill-Gilmore, Fred R Opperdoes, Paul A M Michels.   

Abstract

The activity of pyruvate kinase of Leishmania mexicana is allosterically regulated by fructose 2,6-bisphosphate (F-2,6-P(2)), contrary to the pyruvate kinases from other eukaryotes that are usually stimulated by fructose 1,6-bisphosphate (F-1,6-P(2)). Based on the comparison of the three-dimensional structure of Saccharomyces cerevisiae pyruvate kinase crystallized with F-1,6-P(2) present at the effector site (R-state) and the L. mexicana enzyme crystallized in the T-state, two residues (Lys453 and His480) were proposed to bind the 2-phospho group of the effector. This hypothesis was tested by site-directed mutagenesis. The allosteric activation by F-2,6-P(2) appeared to be entirely abrogated in the mutated enzymes confirming our predictions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943161     DOI: 10.1016/s0014-5793(02)02374-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Jian-kang Jiang; Matthew B Boxer; Matthew G Vander Heiden; Min Shen; Amanda P Skoumbourdis; Noel Southall; Henrike Veith; William Leister; Christopher P Austin; Hee Won Park; James Inglese; Lewis C Cantley; Douglas S Auld; Craig J Thomas
Journal:  Bioorg Med Chem Lett       Date:  2010-04-11       Impact factor: 2.823

2.  Allosteric mechanism of pyruvate kinase from Leishmania mexicana uses a rock and lock model.

Authors:  Hugh P Morgan; Iain W McNae; Matthew W Nowicki; Véronique Hannaert; Paul A M Michels; Linda A Fothergill-Gilmore; Malcolm D Walkinshaw
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

3.  The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.

Authors:  Hugh P Morgan; Iain W McNae; Matthew W Nowicki; Wenhe Zhong; Paul A M Michels; Douglas S Auld; Linda A Fothergill-Gilmore; Malcolm D Walkinshaw
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

4.  Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.

Authors:  Roya Zoraghi; Raymond H See; Peter Axerio-Cilies; Nag S Kumar; Huansheng Gong; Anne Moreau; Michael Hsing; Sukhbir Kaur; Richard D Swayze; Liam Worrall; Emily Amandoron; Tian Lian; Linda Jackson; Jihong Jiang; Lisa Thorson; Christophe Labriere; Leonard Foster; Robert C Brunham; William R McMaster; B Brett Finlay; Natalie C Strynadka; Artem Cherkasov; Robert N Young; Neil E Reiner
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

5.  Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Matthew B Boxer; Jian-kang Jiang; Matthew G Vander Heiden; Min Shen; Amanda P Skoumbourdis; Noel Southall; Henrike Veith; William Leister; Christopher P Austin; Hee Won Park; James Inglese; Lewis C Cantley; Douglas S Auld; Craig J Thomas
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

6.  Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana.

Authors:  Salma Jamal; Vinod Scaria
Journal:  BMC Bioinformatics       Date:  2013-11-19       Impact factor: 3.169

7.  Evolution of energy metabolism and its compartmentation in Kinetoplastida.

Authors:  Véronique Hannaert; Frédéric Bringaud; Fred R Opperdoes; Paul AM Michels
Journal:  Kinetoplastid Biol Dis       Date:  2003-10-28

8.  Organism-adapted specificity of the allosteric regulation of pyruvate kinase in lactic acid bacteria.

Authors:  Nadine Veith; Anna Feldman-Salit; Vlad Cojocaru; Stefan Henrich; Ursula Kummer; Rebecca C Wade
Journal:  PLoS Comput Biol       Date:  2013-07-25       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.